Literature DB >> 8818181

Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid.

E Schmidt1, B Bastian, R Dummer, H P Tony, E B Bröcker, D Zillikens.   

Abstract

Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease with autoantibodies directed against antigens associated with hemidesmosomes of basal keratinocytes. In addition to autoantibodies and activated complement, cellular mechanisms are crucial for blister formation in this disease. Mononuclear cells, which are the first cells infiltrating BP lesions, mainly belong to CD3, CD4+ T-helper (Th) cells. Elevated concentrations of IL-2, IFN gamma, TNF beta, and IL-5 have been recently demonstrated in BP blister fluid. In this study, we were interested in levels of other Th-type cytokines, including IL-3, IL-4, IL-6, IL-10, and GM-CSF in blister fluid of BP. Cytokines were determined by ELISA or bioassay. Levels in the blister fluid from ten BP patients were compared with those in serum samples taken at the time of blister puncture and with those in suction blister fluid of ten healthy volunteers. In blister fluid of BP, we found significantly elevated concentrations of IL-4, IL-6, and IL-10 relative to both concurrent serum samples and suction blister fluid from controls. No differences were detected for either IL-3 or GM-CSF. Our results suggest that IL-4, IL-6, and IL-10 are released at the site of blister formation in BP.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8818181     DOI: 10.1007/bf02507102

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  32 in total

1.  Increased immunoreactive interleukin-5 levels in blister fluids of bullous pemphigoid.

Authors:  H Endo; I Iwamoto; M Fujita; S Okamoto; S Yoshida
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid].

Authors:  A Ambach; D Zillikens; B Klingert; A A Hartmann; G Burg
Journal:  Hautarzt       Date:  1992-02       Impact factor: 0.751

3.  Subclass distribution of IgG autoantibodies in bullous pemphigoid.

Authors:  P Bird; P S Friedmann; N Ling; A G Bird; R A Thompson
Journal:  J Invest Dermatol       Date:  1986-01       Impact factor: 8.551

4.  High levels of soluble CD23 in blister fluid of patients with bullous pemphigoid.

Authors:  E Schmidt; E B Bröcker; D Zillikens
Journal:  Arch Dermatol       Date:  1995-08

5.  Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.

Authors:  G J Giudice; D J Emery; B D Zelickson; G J Anhalt; Z Liu; L A Diaz
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

6.  Cytokine profile of patients with bullous pemphigoid.

Authors:  K Tamaki; K So; T Furuya; M Furue
Journal:  Br J Dermatol       Date:  1994-01       Impact factor: 9.302

7.  High histamine level in the blister fluid of bullous pemphigoid.

Authors:  I Katayama; T Doi; K Nishioka
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

8.  Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.

Authors:  A M Dvorak; M C Mihm; J E Osage; T H Kwan; K F Austen; B U Wintroub
Journal:  J Invest Dermatol       Date:  1982-02       Impact factor: 8.551

9.  IL-4 controls the selective endothelium-driven transmigration of eosinophils from allergic individuals.

Authors:  R Moser; J Fehr; P L Bruijnzeel
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

10.  Morphologic and functional evidence for release of mast-cell products in bullous pemphigoid.

Authors:  B U Wintroub; M C Mihm; E J Goetzl; N A Soter; K F Austen
Journal:  N Engl J Med       Date:  1978-02-23       Impact factor: 91.245

View more
  23 in total

1.  Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8.

Authors:  Françoise Van den Bergh; Steven L Eliason; Brian T Burmeister; George J Giudice
Journal:  Exp Dermatol       Date:  2012-08       Impact factor: 3.960

2.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

Review 3.  Bullous pemphigoid: from bench to bedside.

Authors:  Scott R A Walsh; David Hogg; P Régine Mydlarski
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 4.  Receptor crosstalk: reprogramming B cell receptor signalling to an alternate pathway results in expression and secretion of the autoimmunity-associated cytokine, osteopontin.

Authors:  T L Rothstein; B Guo
Journal:  J Intern Med       Date:  2009-06       Impact factor: 8.989

5.  Immunohistological analysis of immune cells in blistering skin lesions.

Authors:  Mahmoud R Hussein; Fayed Mahammad Nagy Ali; Abd-Elhady M M Omar
Journal:  J Clin Pathol       Date:  2007-01       Impact factor: 3.411

6.  Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.

Authors:  Stefan Tukaj; Denise Grüner; Detlef Zillikens; Michael Kasperkiewicz
Journal:  Cell Stress Chaperones       Date:  2014-05-06       Impact factor: 3.667

7.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

8.  Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.

Authors:  E Schmidt; B Wehr; E M Tabengwa; S Reimer; E-B Bröcker; D Zillikens
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 9.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

10.  Immunomodulator Galectin-9 is Increased in Blood and Skin of Patients with Bullous Pemphigoid.

Authors:  Jasper Pruessmann; Wiebke Pruessmann; Maike M Holtsche; Beke Linnemann; Christoph M Hammers; Nina van Beek; Detlef Zillikens; Enno Schmidt; Christian D Sadik
Journal:  Acta Derm Venereol       Date:  2021-03-23       Impact factor: 3.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.